Transforming growth factor-α and epidermal growth factor receptor in chronic liver disease and hepatocellular carcinoma

Liver

Volumn 19, Issue 4, 1999, Pages 318-325

  Harada, K I ^a   Shiota, G ^a   Kawasaki, H ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

Cell proliferation; Chronic liver diseases; Epidermal growth factor receptor; Hepatocellular carcinoma; Transforming growth factor

Indexed keywords

BETA ACTIN; BILIRUBIN; CYCLINE; EPIDERMAL GROWTH FACTOR RECEPTOR; MESSENGER RNA; TRANSFORMING GROWTH FACTOR ALPHA;

ADULT; AGED; ARTICLE; CHRONIC LIVER DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION FUNCTION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MALE; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCORING SYSTEM;

ACTINS; ADULT; AGED; BIOLOGICAL MARKERS; BLOTTING, SOUTHERN; CARCINOMA, HEPATOCELLULAR; DIAGNOSIS, DIFFERENTIAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS, CHRONIC; HUMANS; LIVER CIRRHOSIS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PROLIFERATING CELL NUCLEAR ANTIGEN; RECEPTOR, EPIDERMAL GROWTH FACTOR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; TRANSFORMING GROWTH FACTOR ALPHA;

EID: 0032773895     PISSN: 01069543     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1478-3231.1999.tb00056.x     Document Type: Article

References (35)

1. DERYNCK R. Transforming growth factor α. Cell 1988; 54: 593-5.
2. MASSAGUE J. Transforming growth factor-α. J Biol Chem 1990; 265: 21393-6.
3. MIETTINEN P J, HEIKINHEIMO K. Transforming growth factor-alpha (TGF-α) and insulin gene expression in human fetal pancreas. Development 1992; 114: 833-40.
4. KURACHI H, MORISHIGE K, IMAI T, et al. Expression of epidermal growth factor and transforming growth factor-alpha in fallopian tube epithelium and their role in embryo-genesis. Horm Res 1994; 41: 48-54.
5. SCHAFF Z, HSIA C C, SAROSI I, TABOR E. Overexpression of transforming growth factor-α in hepatocellular carcinoma and focal nodular hyperplasia from European patients. Hum Pathol. 1994; 25: 644-51.
6. MORIMITSU Y, HSIA C C, KOJIRO M. TABOR E. Nodules of less-differentiated tumor within or adjacent to hepatocellular carcinoma: relative expression of transforming growth factor-α and its receptor in the different areas of tumor. Hum Pathol. 1995; 26: 1126-32.
7. HSIA C C, AXIOTIS C A, DI BISCEGLIE A M, TABOR E. Transforming growth factor-alpha in human hepatocellular carcinoma and coexpression with hepatitis B surface antigen in adjacent liver. Cancer 1992; 70: 1049-56.
8. TOMIYA T, FUJIWARA K. Serum levels of transforming growth factor-α in patients after partial hepatectomy as determined with an enzyme-linked immunosorbent assay. Hepatology 1993; 18: 304-8.
9. MASUHARA M, YASUNAGA M, TANIGAWA K, et al. Expression of hepatocyte growth factor, transforming growth factor α, and transforming growth factor β1 messenger RNA in various human liver diseases and correlation with hepatocyte proliferation. Hepatology 1996; 24: 323-9.
10. COLLIER J D, GULLICK W J, BASSENDINE M F, et al. Expression of transforming growth factor alpha in human hepatocellular carcinoma. Liver 1993; 13: 151-5.
11. KIRA S, NAKANISHI T, SUEMORI S, et al. Expression of transforming growth factor alpha and epidermal growth factor receptor in human hepatocellular carcinoma. Liver 1997; 17: 177-82.
12. JHAPPAN C, STAHLE C, HARKINS R N, et al. TGFα overexpression in transgenic mice induces liver neoplasia and abnormal development of mammary gland and pancreas. Cell 1990; 61: 1137-46.
13. STEINMETZ K L, KLAUNIG J E. Transforming growth factor-α in carcinogen-induced F344 rat hepatic foci. Toxicol Appl Pharmacol 1996; 140: 131-45.
14. TAKAGI H, SHARP R, HAMMERMEISTER C, et al. Molecular and genetic analysis of liver oncogenesis in transforming growth factor α transgenic mice. Cancer Res 1992; 52: 5171-7.
15. WEBBER E M, WU J C, WANG L, et al. Overexpression of transforming growth factor-α causes liver enlargement and increased hepatocyte proliferation in transgenic mice. Am J Pathol 1994; 145: 398-408.
16. LEE L W, RAYMOND V W, TSAO M S, et al. Clonal cosegregation of tumorigenicity with overexpression of c-myc and transforming growth factor α genes in chemically transformed rat liver epithelial cells. Cancer Res 1991; 51: 5238-44.
17. LEE G H, MERLINO G, FAUSTO N. Development of liver tumors in transforming growth factor α transgenic mice. Cancer Res 1992: 52: 5162-70.
18. MEAD J E, FAUSTO N. Transforming growth factor α may be a physiological regulator of liver regeneration by means of an autocrine mechanism. Proc Natl Acad Sci USA 1989; 86: 1558-62.
19. TOMIYA T, FUJIWARA K. Liver regeneration in fulminant hepatitis as elevated by serum transforming growth factor α levels. Hepatology 1996; 23: 253-7.
20. TOMIYA T, FUJIWARA K. Serum transforming growth factor-α level as a marker of hepatocellular carcinoma complicating cirrhosis. Cancer 1996; 77: 1056-60.
21. KATOH M, INAGAKI H, KUROSAWA-OHSAWA K, et al. Detection of transforming growth factor alpha in human urine and plasma. Biochem Biophy Res Commun 1990; 167: 1065-72.
22. MAJIMA Y, FUJIMOTO T, IWAI I, et al. Histological diagnosis of hepatocellular carcinoma by a new technique of ultrasound-guided fine needle biopsy. Acta Hepatol Jpn 1988; 29: 628-32.
23. SUGIHARA S, NAKASHIMA O, KOJIRO M, et al. The morphologic transition in hepatocellular carcinoma: a comparison of the individual histologic features disclosed by ultrasound-guided fine needle biopsy with those of autopsy. Cancer 1992; 70: 1488-92.
24. CHOMEZYNESKI P, SACCHI N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-9.
25. GLATSTEIN I Z, CHOI Y M, OSATHANONDH R, YEH J. Human fetal uterine cells: culture, characterization, and analysis of growth factor receptor gene expression. J Clin Endocrinol Metab 1994; 79: 126-33.
26. REISS K, PORCU P, SELL C, et al. The insulin-like growth factor 1 receptor is required for the proliferation of hematopoietic cells. Oncogene 1992; 7: 2243-8.
27. SAMBROOK J, FRITISCH E F, MANIATIS T. DNA sequencing in molecular cloning: a laboratory manual; Cold Spring harbor Press, 1989.
28. SHIOTA G, WANG C T, NAKAMURA T, SCHMIDT E V. Hepatocyte growth factor in transgenic mice: effects on hepatocyte growth, liver regeneration and gene expression Hepatology 1994; 19; 962-72.
29. ALMENDRAL J M, HUEBSCH D, BLUNDELL P A, et al. Cloning and sequence of the human nuclear protein cyclin: homology with DNA-binding proteins. Proc Natl Acad Sci USA 1987; 84: 1575-9.
30. OKANO J, SHIOTA G, KAWASAKI H. Protective action of hepatocyte growth factor for acute liver injury caused by D-galactosamine in transgenic mice. Hepatology 1997; 26: 1241-9.
31. MORIMITSU Y, KLEINER D E, CONJEEVARAM H S, et al. Expression of transforming growth factor alpha in the liver before and after interferon alpha therapy for chronic hepatitis B. Hepatology 1995; 22: 1021-6.
32. TANAKA S, TAKENAKA K, MATSUSHITA T, et al. Hepatitis C virus replication is associated with expression of transforming growth factor-α and insulin-like growth factor-II in cirrhotic livers. Dig Dis Sci 1996; 41: 208-15.
33. BURR A W, TOOLE K, MATHEW J, et al. Transforming growth factor-α expression is altered during experimental hepatocarcinogenesis. J Pathol 1996; 179: 276-82.
34. KISS A, WANG N-J, THORGEIRSSON S S. Analysis of transforming growth factor (TGF)-α/Epidermal growth factor receptor, hepatocyte growth factor/c-met, TGF-β receptor type II, and p53 expression in human hepatocellular carcinomas. Clin Cancer Res 1997; 3: 1059-66.
35. PARK B C, HUH M H, SEO J H. Differential expression of transforming growth factor α and insulin-like growth factor II in chronic active hepatitis B, cirrhosis and hepatocellular carcinoma. J Hepatol 1995; 22: 286-94.